*Result*: Targeting of apoptotic pathways by SMAC or BH3 mimetics distinctly sensitizes paclitaxel-resistant triple negative breast cancer cells
*Author/editor-in-chief*:
*Publication*:
Freiburg : Universität, 2019
*Physical description scale*:
1 Online-Ressource
*Format*:
*Language*:
*eng*
*Notes*:
OncoTarget. - 8, 28 (2017) , 45088-45104, ISSN: 1949-2553
*DOI*:
10.18632/oncotarget.15125